GGrantIndex
← Leaderboards

Charles C Hong

Massachusetts General Hospital

$9,157,416
Attributed
$10,076,700
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,076,700 · 7
VA$0 · 1

By mechanism

R01$9,408,110 · 6
K08$668,590 · 1
I01$0 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Small Molecule

Research focus

Small MoleculeIn VivoSignal TransductionIn VitroBaseHeartHeart FailureCardiacCardiac MyocytesCellsTissuesBlood VesselsInduced Pluripotent Stem CellLightFutureNovel TherapeuticsHeart DiseasesGenesAnalogProgramsMyocardialCell PhysiologyPharmaceutical PreparationsCardiovascular System

Grant awards (32)

GPR68 as a novel modulator of septic lung injury$612,334
R01 · FY2025 · HL
Mechanistic Insights into The Role of Microtubule Organizing Centers on Cardiomyocyte Structure and Function$518,486
R01 · FY2025 · HL · contact PI
GPR68 as a novel modulator of septic lung injury$604,629
R01 · FY2024 · HL
Mechanistic Insights into The Role of Microtubule Organizing Centers on Cardiomyocyte Structure and Function$510,145
R01 · FY2024 · HL · contact PI
GPR68 as a novel modulator of septic lung injury$621,605
R01 · FY2023 · HL
Mechanistic Insights into The Role of Microtubule Organizing Centers on Cardiomyocyte Structure and Function$510,230
R01 · FY2023 · HL · contact PI
Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome$386,250
R01 · FY2021 · HL · contact PI
Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome$386,250
R01 · FY2020 · HL · contact PI
Chemical Genetic Analysis of Vertebrate Development$498,556
R01 · FY2019 · GM · contact PI
Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome$386,250
R01 · FY2019 · HL · contact PI
Chemical Genetic Analysis of Vertebrate Development$458,592
R01 · FY2018 · GM · contact PI
Novel Approach to Enhance Myocardial Performance and Improve Heart Failure Outcome$395,000
R01 · FY2018 · HL · contact PI
Chemical Genetic Analysis of Vertebrate Development$40,871
R01 · FY2018 · GM · contact PI
Chemical Genetic Analysis of Vertebrate Development$509,851
R01 · FY2017 · GM · contact PI
Chemical Genetic Analysis of Vertebrate Development$509,851
R01 · FY2016 · GM · contact PI
Cardiac Induction by Small Molecule BMP Inhibitors$435,821
R01 · FY2014 · HL · contact PI
Regulation and Maintenance of Cardiac Muscle Sarcomere Integrity$435,511
R01 · FY2014 · HL · contact PI
Cardiac Induction by Small Molecule BMP Inhibitors$367,567
R01 · FY2013 · HL · contact PI
Cardiac Induction by Small Molecule BMP Inhibitors$56,503
R01 · FY2013 · HL · contact PI
Chemical Induction of Cardiomyogenesis$0
I01 · FY2013 · VA · contact PI
Cardiac Induction by Small Molecule BMP Inhibitors$386,100
R01 · FY2012 · HL · contact PI
Chemical Induction of Cardiomyogenesis$0
I01 · FY2012 · VA · contact PI
Cardiac Induction by Small Molecule BMP Inhibitors$390,000
R01 · FY2011 · HL · contact PI
Chemical Induction of Cardiomyogenesis$0
I01 · FY2011 · VA · contact PI
Chemical Induction of Cardiomyogenesis$0
I01 · FY2011 · VA · contact PI
Cardiac Induction by Small Molecule BMP Inhibitors$387,708
R01 · FY2010 · HL · contact PI
Chemical Genetics of Vertebrate Vascular Development$133,718
K08 · FY2009 · HL · contact PI
Chemical Genetics of Vertebrate Vascular Development$133,718
K08 · FY2008 · HL · contact PI
Chemical Genetics of Vertebrate Vascular Development$133,718
K08 · FY2007 · HL · contact PI
Chemical Genetics of Vertebrate Vascular Development$100,289
K08 · FY2006 · HL · contact PI
Chemical Genetics of Vertebrate Vascular Development$33,429
K08 · FY2006 · HL · contact PI
Chemical Genetics of Vertebrate Vascular Development$133,718
K08 · FY2005 · HL